Stocks Health care TNON
NASDAQ · Health careTenon Medical, Inc. (TNON)
Tenon Medical, Inc. brought in $5.3M of revenue over the twelve months to June 30, 2026, up 80.3% from a year earlier. It posted a net loss of $13.7M. In fiscal 2025 capital spending exceeded operating cash flow by $11M. At June 30, 2026 it held $1.7M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 13, 2026.
Key facts about Tenon Medical, Inc.
- Net worth
- Tenon Medical, Inc. has a market value (market cap) of $1.2M at the latest share price, and shareholders' equity of -$1.7M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $3.9M (+20.4% year on year), with a net loss of $12.6M. Over the 12 months to June 30, 2026: revenue $5.3M, net loss $13.7M.
- Cash flow
- In fiscal 2025 operations used $10.7M of cash.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on August 13, 2026 and covers the period to June 30, 2026. Open on SEC EDGAR
What Tenon Medical, Inc. does
Tenon Medical, Inc. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker TNON.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $3.9M | -$12.6M | -$1.70 | -$11M |
| 2024 | $3.3M | -$13.7M | -$11.26 | -$10.1M |
| 2023 | $2.9M | -$15.6M | -$68.64 | -$12.5M |
| 2022 | $691K | -$18.9M | -$188.74 | -$12.9M |
| 2022 | $160K | -$7M | -$624.60 | -$4.4M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where TNON ranks in Health care
Latest SEC filings
What Tenon Medical, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- October 5, 2026
- September 16, 2026
- September 9, 2026Other event 8-K
- September 2, 2026
- August 31, 2026
- August 26, 2026Material agreement 8-K/A
- August 24, 2026Other event 8-K
- August 17, 2026
- August 14, 2026Passive stake (5% or more) SCHEDULE 13G
- August 13, 2026Quarterly report 10-Q · period to June 30, 2026Revenue rose 127% to $1.3M versus the same quarter last year; diluted EPS -$12.35 versus -$12.76.
Insider trades
What the people running Tenon Medical, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
Insiders bought $500.2K and sold $605.7K worth of shares in the last 90 days.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| September 10, 2026 | Hrt Financial LP10% owner | Bought | 31,227 | $91.2K |
| September 10, 2026 | Hrt Financial LP10% owner | Bought | 28,267 | $113.6K |
| September 10, 2026 | Hrt Financial LP10% owner | Bought | 8,431 | $41.5K |
| September 10, 2026 | Hrt Financial LP10% owner | Sold | 65,582 | $364.6K |
| September 9, 2026 | Hrt Financial LP10% owner | Sold | 50,395 | $131.5K |
| September 9, 2026 | Hrt Financial LP10% owner | Bought | 39,508 | $134.3K |
| September 9, 2026 | Hrt Financial LP10% owner | Sold | 9,948 | $42.5K |
| September 9, 2026 | Williamson KevinChief Financial Officer | Shares withheld for tax | 11 | $38 |
Who owns TNON
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| SiVantage Inc.13D, may seek influence | 12.5% | August 8, 2025 |
| Armistice Capital, LLC13G, passive with 1 related filers | 9.99% | August 14, 2026 |
Largest institutional holders
Insiders
11 insiders reported holding 1,812,773 shares in total, about $3.3M at the last price.
| Holder | Shares |
|---|---|
| Geist Wyatt D.Chief Innovation Officer | 644,735487,166 held indirectly |
| Grawey Nathaniel A.Chief Commercial Officer | 482,865243,584 held indirectly |
| Foster Steven MCEO and President, Director | 285,840 |
| Ginn RichardChief Technology Officer, Director | 167,357 |
| Ferrari RichardDirector | 135,243 |
| Jacques Kristine MDirector | 20,876 |
| Howard IvanDirector | 20,251 |
| Hochschuler StephenDirector | 18,670 |
| Weigle Robert KDirector | 18,517 |
| Hrt Financial LP10% owner | 15,839 |
Questions about TNON
What does Tenon Medical, Inc. do?
Tenon Medical, Inc. is a company in the Health care sector, listed on NASDAQ as TNON. Its shares trade on NASDAQ under the ticker TNON.
What is Tenon Medical, Inc.'s net worth?
Tenon Medical, Inc. has a market value (market cap) of $1.2M at the latest share price, and shareholders' equity of -$1.7M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Tenon Medical, Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $13.7M on revenue of $5.3M.
How much revenue does Tenon Medical, Inc. make?
Over the twelve months to June 30, 2026 Tenon Medical, Inc. reported revenue of $5.3M. That is 80.3% more than a year earlier.
When did Tenon Medical, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 13, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the shelf registration to sell securities from October 5, 2026.
Similar companies
Compare TNON with
Follow TNON
Get an email when Tenon Medical, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Tenon Medical, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.